Chrystal Capital advises CEIBA Healthcare on $10m fundraise
Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based entrepreneurial corporate finance and investment house, is pleased to announce that it has acted as financial advisor to CEIBA Healthcare (“CEIBA”), a Healthcare Technology company that is focused on Connectivity, Telehealth and Telemedicine on its US$10m placing. The company’s products are FDA registered and have won government contracts, signed partnership agreements in the US and are deployed in the Middle East and the US.
“We are delighted to have supported CEIBA, one of the Telehealth market’s most exciting technology companies. CEIBA’s fundraise was led by two healthcare focused private equity groups and supported by family offices from within Chrystal’s network. The company’s connectivity product is interoperable with over 95% of all medical devices in an ICU, while their clinical decision and remote patient monitoring platforms products are revolutionary. Ceiba has solved the interoperability issue between medical devices in an ICU and offers wave form technology to virtual teams across the hospital network. We look forward to seeing the company grow globally”
About CEIBA Healthcare
Established in 2016, Ceiba Healthcare Group has developed healthcare technology products and solutions to turn ICU beds into true digital form. Ceiba eConnect Smart IoMT box captures data from medical devices and using Ceiba eClinics Platform displays the data in real time in visible, recordable and actionable format. Ceiba technology transforms hospitals in achieving limitless medical device integration irrespective of brand and real time patient data monitoring. With digital ICU beds, hospitals can provide full telehealth solutions and achieve efficiencies saving time and money while providing better patient care.
Ceiba’s AI-based algorithmic predictive analytics engine, ZeqAI, accurately predicts Sepsis, Septic Shock, Mortality, Length of Stay and Acute Kidney failure, and can be applied to predict other diseases. ZeqAI analyses hundreds of data parameters at high frequency from endless medical devices via Ceiba eConnect Smart IoMT box to predict whether or not a patient is going to develop Septic Shock 48 hours before onset and provide real time information to assist medical professionals. Please visit https://www.ceiba-healthcare.com/about-us.html for more.
For further information please contact:
Raj Karia
Raj.Karia@chrystalcapital.com
https://www.chrystalcapital.com